CLINICAL TRIALS PROFILE FOR HEXAMINOLEVULINATE HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for Hexaminolevulinate Hydrochloride
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00052637 ↗ | Cystoscopy and Hexyl 5-Aminolevulinate in Detecting Carcinoma In Situ in Patients With Bladder Cancer | Completed | National Cancer Institute (NCI) | Phase 3 | 2001-09-01 | RATIONALE: Diagnostic procedures such as cystoscopy may improve the ability to detect cancer and to determine the extent of disease. PURPOSE: Diagnostic trial to compare the effectiveness of cystoscopy using hexyl 5-aminolevulinate and two light sources in detecting carcinoma in situ in patients who have bladder cancer. |
| NCT00052637 ↗ | Cystoscopy and Hexyl 5-Aminolevulinate in Detecting Carcinoma In Situ in Patients With Bladder Cancer | Completed | Photocure | Phase 3 | 2001-09-01 | RATIONALE: Diagnostic procedures such as cystoscopy may improve the ability to detect cancer and to determine the extent of disease. PURPOSE: Diagnostic trial to compare the effectiveness of cystoscopy using hexyl 5-aminolevulinate and two light sources in detecting carcinoma in situ in patients who have bladder cancer. |
| NCT00285701 ↗ | Early Detection of Polyps and Colon Cancer by Fluorescence Imaging - a Dose-finding Study | Completed | KARL STORZ Endoscopy-America, Inc. | Phase 1/Phase 2 | 2006-07-01 | Patients referred for colon inspection (colonoscopy) due to suspicion of colon polyps/cancer will receive local administration of hexaminolevulinate (HAL) prior to colon inspection. Blue light illumination will induce red fluorescence of polyps and tumours, improving detection of the polyps and tumors. Different HAL doses will be tested to find the optimal image conditions. Tolerability measurements will be performed to ensure patient safety. |
| NCT00285701 ↗ | Early Detection of Polyps and Colon Cancer by Fluorescence Imaging - a Dose-finding Study | Completed | Photocure | Phase 1/Phase 2 | 2006-07-01 | Patients referred for colon inspection (colonoscopy) due to suspicion of colon polyps/cancer will receive local administration of hexaminolevulinate (HAL) prior to colon inspection. Blue light illumination will induce red fluorescence of polyps and tumours, improving detection of the polyps and tumors. Different HAL doses will be tested to find the optimal image conditions. Tolerability measurements will be performed to ensure patient safety. |
| NCT00369018 ↗ | A Dose-finding Study of MAL and HAL Photodynamic Therapy of Cervical Premalignant Lesions. | Completed | Photocure | Phase 1/Phase 2 | 2006-08-01 | The study will determine the best drug (MAL or HAL) dosage for photodynamic therapy of cervical precancerous lesions (dysplasia) in women that are referred for conisation (surgery). |
| NCT00634621 ↗ | Effectiveness of Hexaminolevulinate (Hexvix) in the Diagnosis and Treatment of Patients With Non-invasive Bladder Cancer | Completed | GE Healthcare | 2008-02-01 | The purpose of this study is to determine the effectiveness of hexaminolevulinate (Hexvix) in the diagnosis and treatment of patients with non-invasive bladder cancer and if it results in a change in patient management. | |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Hexaminolevulinate Hydrochloride
Condition Name
Clinical Trial Locations for Hexaminolevulinate Hydrochloride
Trials by Country
Clinical Trial Progress for Hexaminolevulinate Hydrochloride
Clinical Trial Phase
Clinical Trial Sponsors for Hexaminolevulinate Hydrochloride
Sponsor Name
